MAGISTRAL PREPARATION FOR TREATMENT OF PSORIASIS AND ECZEMA WITH ICHTIOL AS ACTIVE INGREDIENT
Keywords:
ichthyol, magistral preparation, physicochemical characteristics, psoriasis, eczemaAbstract
The manufacturing of magistral and galenic medicines in a pharmacy should be carried out in accordance with the applicable regulations and defined conditions, so that the patient undoubtedly receives a medicine of proper quality, regardless of the place of manufacture. They have an undeniable importance in pharmaceutical and clinical practice, especially in the treatment of dermatological diseases, and have been the pharmaceutical preparations of first choice for centuries.
Ichthyol, used since the 19th century to treat psoriasis, eczema, ulcers, seborrheic dermatitis, and boils, is still an effective topical agent. It is commonly formulated in the form of hydrophobic ointments, which form an occlusive layer and offer deep rehydration, or suspensions, for easier application, which can be formulated with a variety of pharmaceutical-technological procedures. The main goal is to obtain a galenic preparation with rheological properties that allow easy application, rapid absorption, homogeneous distribution of the active substance, adapted according to the pathophysiology of the desired site of administration, by the application of excipients that do not cause local irritation and other side effects. Achieving these goals requires professional approach for the selection of excipients, their ratio, preparation procedure, critical consideration of parameters, and analytical methods for quality control.
References
AL-Rawi, Dr. J. R., & Al-Azawy, Dr. F. K. (2025). Efficacy of Topical Ichthammol in Treatment of Mild Plaque Psoriasis. South Asian Research Journal of Pharmaceutical Sciences, 7(01), 11–19. https://doi.org/10.36346/sarjps.2025.v07i01.003
Brazzini, B., & Pimpinelli, N. (2002). New and established topical corticosteroids in dermatology: Clinical Pharmacology and Therapeutic Use. American Journal of Clinical Dermatology, 3(1), 47–58. https://doi.org/DOI: 10.2165/00128071-200203010-00005
Daniels, R., & Knie, U. (2007). Galenics of dermal products – vehicles, properties and drug release. JDDG: Journal Der Deutschen Dermatologischen Gesellschaft, 5(5), 367–383. https://doi.org/10.1111/j.1610-0387.2007.06321.x
Glogowski, A., Kolodziejska, J., Kolodziejczyk, M. K., & Zgoda, M. M. (2015). The influence of the viscosity of the ointment vehicles magisterial topical preparations, on the speed transfer of biologically active substances. Current Issues in Pharmacy and Medical Sciences, 28(3), 212–218. https://doi.org/10.1515/cipms-2015-0075
Kitagawa, S., Fujiwara, M., Okinaka, Y., Yutani, R., & Teraoka, R. (2015). Effects of Mixing Procedure Itself on the Structure, Viscosity, and Spreadability of White Petrolatum and Salicylic Acid Ointment and the Skin Permeation of Salicylic Acid. CHEMICAL ^|^ PHARMACEUTICAL BULLETIN, 63(1), 43–48. https://doi.org/10.1248/cpb.c14-00558
Kleesz, P., Darlenski, R., & Fluhr, J. W. (2012). Full-Body Skin Mapping for Six Biophysical Parameters: Baseline Values at 16 Anatomical Sites in 125 Human Subjects. Skin Pharmacology and Physiology, 25(1), 25–33. https://doi.org/10.1159/000330721
Lein, A., & Oussoren, C. (2015). Dermal. In Y. Bouwman-Boer, V. Fenton-May, & P. Le Brun (Eds.), Practical Pharmaceutics (pp. 229–263). Cham: Springer International Publishing. https://doi.org/10.1007/978-3-319-15814-3_12
Oakley, R., Arents, B. W. M., Lawton, S., Danby, S., & Surber, C. (2021). Topical corticosteroid vehicle composition and implications for clinical practice. Clinical and Experimental Dermatology, 46(2), 259–269. https://doi.org/10.1111/ced.14473
Pharmaceutical Preparations. (2023). In European Pharmacopoeia (11th ed., pp. 880–882).
Segger, D., Aßmus, U., Brock, M., Erasmy, J., Finkel, P., Fitzner, A., … [Members of the DGK German Society for Scientific and Applied Cosmetics »Skin Cleansing« Group]. (2008). Multicenter study on measurement of the natural pH of the skin surface. International Journal of Cosmetic Science, 30(1), 75–75. https://doi.org/10.1111/j.1468-2494.2007.00403_1.x
Uriel, M., Marro, D., & Gómez Rincón, C. (2023). An Adequate Pharmaceutical Quality System for Personalized Preparation. Pharmaceutics, 15(3), 800. https://doi.org/10.3390/pharmaceutics15030800
Watson, C. J., Whitledge, J. D., Siani, A. M., & Burns, M. M. (2021). Pharmaceutical Compounding: A History, Regulatory Overview, and Systematic Review of Compounding Errors. Journal of Medical Toxicology, 17(2), 197–217. https://doi.org/10.1007/s13181-020-00814-3
Williams, A. C. (2018). Topical and transdermal drug delivery. In Aulton’s Pharmaceutics: The design and manufacture of medicines (5th ed., pp. 715–918). London: Elsevier Science.
Zsikó, Csányi, Kovács, Budai-Szűcs, Gácsi, & Berkó. (2019). Methods to Evaluate Skin Penetration In Vitro. Scientia Pharmaceutica, 87(3), 19. https://doi.org/10.3390/scipharm87030019